Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Synthesis of "Dahlia-Like" Hydrophilic Fluorescent Carbon Nanohorn as a Bio-Imaging PROBE.

Parasuraman PS, Parasuraman VR, Anbazhagan R, Tsai HC, Lai JY.

Int J Mol Sci. 2019 Jun 18;20(12). pii: E2977. doi: 10.3390/ijms20122977.

2.
3.

Targeted Knock-In Mice with a Human Mutation in GRTH/DDX25 Reveals the Essential Role of Phosphorylated GRTH in Spermatid Development during Spermatogenesis.

Kavarthapu R, Anbazhagan R, Raju M, Morris CT, Pickel J, Dufau ML.

Hum Mol Genet. 2019 Apr 22. pii: ddz079. doi: 10.1093/hmg/ddz079. [Epub ahead of print]

PMID:
31009948
4.

Interaction of positive coactivator 4 with histone 3.3 protein is essential for transcriptional activation of the luteinizing hormone receptor gene.

Zhao P, Kavarthapu R, Anbazhagan R, Liao M, Dufau ML.

Biochim Biophys Acta Gene Regul Mech. 2018 Oct;1861(10):971-981. doi: 10.1016/j.bbagrm.2018.09.002. Epub 2018 Sep 13.

5.

Fabrication of silver seeds and nanoparticle on core-shell Ag@SiO2 nanohybrids for combined photothermal therapy and bioimaging.

Manivannan K, Cheng CC, Anbazhagan R, Tsai HC, Chen JK.

J Colloid Interface Sci. 2019 Mar 1;537:604-614. doi: 10.1016/j.jcis.2018.11.051. Epub 2018 Nov 14.

PMID:
30472636
6.

MoS2-Gd Chelate Magnetic Nanomaterials with Core-Shell Structure Used as Contrast Agents in in Vivo Magnetic Resonance Imaging.

Anbazhagan R, Su YA, Tsai HC, Jeng RJ.

ACS Appl Mater Interfaces. 2016 Jan 27;8(3):1827-35. doi: 10.1021/acsami.5b09722. Epub 2016 Jan 12.

PMID:
26714060
7.

Design, synthesis, computational calculation and biological evaluation of some novel 2-thiazolyl hydrazones.

Anbazhagan R, Sankaran KR.

Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jan 25;135:984-93. doi: 10.1016/j.saa.2014.06.160. Epub 2014 Aug 4.

PMID:
25168236
8.
9.

(E)-1-Diphenyl-methyl-idene-2-[(1H-indol-3-yl)methyl-idene]hydrazine.

Archana R, Anbazhagan R, Sankaran KR, Thiruvalluvar A, Butcher RJ.

Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 5;66(Pt 7):o1586. doi: 10.1107/S1600536810020702.

10.

1-Diphenyl-methyl-ene-2-(9H-fluoren-9-yl-idene)hydrazine.

Archana R, Anbazhagan R, Sankaran KR, Thiruvalluvar A, Butcher RJ.

Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 13;66(Pt 2):o345. doi: 10.1107/S160053681000070X.

11.

Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.

Kelly KA, Bardeesy N, Anbazhagan R, Gurumurthy S, Berger J, Alencar H, Depinho RA, Mahmood U, Weissleder R.

PLoS Med. 2008 Apr 15;5(4):e85. doi: 10.1371/journal.pmed.0050085.

12.

Detection of early prostate cancer using a hepsin-targeted imaging agent.

Kelly KA, Setlur SR, Ross R, Anbazhagan R, Waterman P, Rubin MA, Weissleder R.

Cancer Res. 2008 Apr 1;68(7):2286-91. doi: 10.1158/0008-5472.CAN-07-1349.

13.

Endosomal colocalization of melanocortin-3 receptor and beta-arrestins in CAD cells with altered modification of AKT/PKB.

Nyan DC, Anbazhagan R, Hughes-Darden CA, Wachira SJ.

Neuropeptides. 2008 Jun;42(3):355-66. doi: 10.1016/j.npep.2007.12.007. Epub 2008 Mar 4.

PMID:
18291523
14.

Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis.

Makino H, Tajiri T, Miyashita M, Sasajima K, Anbazhagan R, Johnston J, Gabrielson E.

Dis Esophagus. 2005;18(1):37-40.

PMID:
15773840
15.

Molecular classification of lung cancer: a cross-platform comparison of gene expression data sets.

Parmigiani G, Garrett E, Anbazhagan R, Gabrielson E.

Chest. 2004 May;125(5 Suppl):103S. No abstract available.

PMID:
15136439
16.

A cross-study comparison of gene expression studies for the molecular classification of lung cancer.

Parmigiani G, Garrett-Mayer ES, Anbazhagan R, Gabrielson E.

Clin Cancer Res. 2004 May 1;10(9):2922-7.

17.

Microarray data assembler.

Anbazhagan R.

Bioinformatics. 2003 Jan;19(1):157-8.

PMID:
12499309
18.

Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells.

Delsite R, Kachhap S, Anbazhagan R, Gabrielson E, Singh KK.

Mol Cancer. 2002 Nov 12;1:6.

19.

Mucinous cancers have fewer genomic alterations than more common classes of breast cancer.

Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E.

Breast Cancer Res Treat. 2002 Dec;76(3):255-60.

PMID:
12462386
20.

Microarray Assistant clone organizer and array simulator.

Anbazhagan R.

Biotechniques. 2002 Jun;32(6):1398-402.

21.

A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.

Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB.

Nat Genet. 2002 Jun;31(2):141-9. Epub 2002 May 6.

PMID:
11992124
22.

Functional genomics, gene arrays, and the future of pathology.

Gabrielson E, Berg K, Anbazhagan R.

Mod Pathol. 2001 Dec;14(12):1294-9. Review.

23.

Spreadsheet-based program for the analysis of DNA methylation.

Anbazhagan R, Herman JG, Enika K, Gabrielson E.

Biotechniques. 2001 Jan;30(1):110-4.

24.

Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles.

Anbazhagan R, Tihan T, Bornman DM, Johnston JC, Saltz JH, Weigering A, Piantadosi S, Gabrielson E.

Cancer Res. 1999 Oct 15;59(20):5119-22.

25.
26.

Spreadsheet-based program for alignment of overlapping DNA sequences.

Anbazhagan R, Gabrielson E.

Biotechniques. 1999 Jun;26(6):1180-5.

27.

Microsatellite instability is uncommon in breast cancer.

Anbazhagan R, Fujii H, Gabrielson E.

Clin Cancer Res. 1999 Apr;5(4):839-44.

28.

Absence of intragenic mismatch mutations in small cell lung cancers with microsatellite instability.

Anbazhagan R, Merlo A, Sidransky D, Gabrielson E.

Int J Cancer. 1999 Mar 15;80(6):944-5. No abstract available.

29.

Breast development gives insights into breast disease.

Osin PP, Anbazhagan R, Bartkova J, Nathan B, Gusterson BA.

Histopathology. 1998 Sep;33(3):275-83.

PMID:
9777395
30.

The development of epithelial phenotypes in the human fetal and infant breast.

Anbazhagan R, Osin PP, Bartkova J, Nathan B, Lane EB, Gusterson BA.

J Pathol. 1998 Feb;184(2):197-206.

PMID:
9602712
31.

Allelic loss of chromosomal arm 8p in breast cancer progression.

Anbazhagan R, Fujii H, Gabrielson E.

Am J Pathol. 1998 Mar;152(3):815-9.

32.

Homeobox genes: molecular link between congenital anomalies and cancer.

Anbazhagan R, Raman V.

Eur J Cancer. 1997 Apr;33(4):635-7.

PMID:
9274447
33.

Expression of integrin subunits in the human infant breast correlates with morphogenesis and differentiation.

Anbazhagan R, Bartkova J, Stamp G, Pignatelli M, Gusterson B.

J Pathol. 1995 Jul;176(3):227-32. Erratum in: J Pathol 1996 Feb;178(2):235. Bartek J [corrected to Bartkova J].

PMID:
7674085
34.
35.

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.

Nathan B, Gusterson B, Jadayel D, O'Hare M, Anbazhagan R, Jayatilake H, Ebbs S, Micklem K, Price K, Gelber R, et al.

Ann Oncol. 1994 May;5(5):409-14.

PMID:
7915536
36.

Immunolocalisation of cell surface peptidases in the developing human breast.

Atherton AJ, Anbazhagan R, Monaghan P, Bartek J, Gusterson BA.

Differentiation. 1994 Apr;56(1-2):101-6.

PMID:
7913070
37.

Expression of BCL-2 in the developing human fetal and infant breast.

Nathan B, Anbazhagan R, Clarkson P, Bartkova J, Gusterson B.

Histopathology. 1994 Jan;24(1):73-6.

PMID:
8144145
38.

Prenatal factors may influence predisposition to breast cancer.

Anbazhagan R, Gusterson BA.

Eur J Cancer. 1994;30A(1):1-3. No abstract available.

PMID:
8142148
39.

Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal women.

Nathan B, Bates T, Anbazhagan R, Norman AR.

Br J Surg. 1993 Jan;80(1):43. No abstract available.

PMID:
8428290
40.

Prenatal influences and breast cancer.

Anbazhagan R, Nathan B, Gusterson BA.

Lancet. 1992 Dec 12;340(8833):1477-8. No abstract available.

PMID:
1360602
41.

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Säve-Söderborgh J, Anbazhagan R, Styles J, Rudenstam CM, Golouh R, Reed R, et al.

J Clin Oncol. 1992 Jul;10(7):1049-56.

PMID:
1351538
42.

Reversed cerebral asymmetry and breast cancer.

Anbazhagan R, Gusterson BA.

Lancet. 1992 Apr 25;339(8800):1056. No abstract available.

PMID:
1349079
43.

Growth and development of the human infant breast.

Anbazhagan R, Bartek J, Monaghan P, Gusterson BA.

Am J Anat. 1991 Dec;192(4):407-17.

PMID:
1781450
44.

Expression of p53 in premalignant and malignant squamous epithelium.

Gusterson BA, Anbazhagan R, Warren W, Midgely C, Lane DP, O'Hare M, Stamps A, Carter R, Jayatilake H.

Oncogene. 1991 Oct;6(10):1785-9.

PMID:
1717923
45.

Helix pomatia in breast cancer.

Taylor CW, Anbazhagan R, Jayatilake H, Adams A, Gusterson BA, Price K, Gelber RD, Goldhirsch A.

Lancet. 1991 Aug 31;338(8766):580-1. No abstract available.

PMID:
1678842
46.

Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer.

Anbazhagan R, Gelber RD, Bettelheim R, Goldhirsch A, Gusterson BA.

Ann Oncol. 1991 Jan;2(1):47-53.

PMID:
1672597
47.

The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.

Anbazhagan R, Sakakura T, Gusterson BA.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59(1):59-63.

PMID:
1696042

Supplemental Content

Loading ...
Support Center